Terminated OBSERVATIONAL NCT04335747

COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases

Sponsor: Salome Kristensen

Conditions Axial Spondyloarthritis Giant Cell Arteritis Psoriatic Arthritis Rheumatoid Arthritis Systemic Lupus Erythematosus

Interventions COVID-19 infection

Updated 8 times since 2020 Last updated: Jul 20, 2021 Started: Apr 23, 2020 Primary completion: Jul 1, 2021 Completion: Jul 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Low recruitment rate

Other Axial Spondyloarthritis trials with similar outcome

Browse all Axial Spondyloarthritis trials

This observational or N/A phase trial investigates Axial Spondyloarthritis and Giant Cell Arteritis and is currently terminated or withdrawn. Salome Kristensen leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Dec 2021 — Jul 2024 [monthly]

Terminated
Sep 2021 — Dec 2021 [monthly]

Terminated

Status: Recruiting → Terminated
Jan 2021 — Sep 2021 [monthly]

Recruiting

▶ Show 3 earlier versions

Nov 2020 — Jan 2021 [monthly]

Recruiting
Jun 2020 — Nov 2020 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
May 2020 — Jun 2020 [monthly]

Not Yet Recruiting

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Salome Kristensen

Data source: Aalborg University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aalborg, Denmark